Advanced in ABO Incompatibility

Klemens B. Budde

Universitair Ziekenhuis Brussel
Brussels, BRU, BE 
Advanced in ABO Incompatibility
Universitair Ziekenhuis Brussel
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Klemens Budde practices in Brussels, Belgium. Budde is rated as an Advanced expert by MediFind in the treatment of ABO Incompatibility. Their top areas of expertise are Chronic Kidney Disease, Tuberous Sclerosis Complex, Tuberous Sclerosis, Kidney Transplant, and Nephrectomy.

Their clinical research consists of co-authoring 433 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of ABO Incompatibility.

Locations

Universitair Ziekenhuis Brussel
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Enrollment Status: Terminated
Publish Date: July 23, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 3
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection in Kidney Transplant Recipient with Donor-specific Antibodies
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection in Kidney Transplant Recipient with Donor-specific Antibodies
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

432 Total Publications

CAKUT subtypes determine the rate of progression to kidney failure - an adult patient cohort study.
CAKUT subtypes determine the rate of progression to kidney failure - an adult patient cohort study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Budde's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile